An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.

Antagonists can be classified as competitive or noncompetitive based on their interaction with the receptor.

A competitive antagonist competes with an agonist to bind to the receptor at the same site. It reduces the number of available receptors and diminishes the effect of the agonist. Its effect is reversible, as increasing the agonist concentration restores the binding between the agonist and the receptor, counteracting the antagonist's actions. The effectiveness of a competitive antagonist can be overcome by increasing the concentration of the agonist. Examples of competitive antagonists include naloxone (used to reverse opioid overdose) and propranolol (used to block β-adrenergic receptors in the heart).

In contrast, noncompetitive antagonists bind covalently to the active site of the receptor. Even increasing the concentration of agonists cannot displace these irreversible antagonists from the receptor. As a result, noncompetitive antagonists lower the maximal effect of the agonist and reduce its efficacy. Examples of noncompetitive antagonists include phenoxybenzamine (used to block ɑ-adrenergic receptors) and ketamine (an NMDA receptor antagonist used for anesthesia).

Tags
Drug receptor InteractionAntagonistCompetitive AntagonistNoncompetitive AntagonistReceptor BindingAgonistPharmacological EffectsNeurotransmittersHormonesNaloxonePropranololPhenoxybenzamineKetamine

장에서 4:

article

Now Playing

4.13 : Drug-Receptor Interaction: Antagonist

Pharmacodynamics

1.9K Views

article

4.1 : 약물 작용의 원칙

Pharmacodynamics

5.1K Views

article

4.2 : 약물 작용의 목표: 개요

Pharmacodynamics

4.2K Views

article

4.3 : 신호 전달: 개요

Pharmacodynamics

7.8K Views

article

4.4 : 변환기 메커니즘: G 단백질 결합 수용체

Pharmacodynamics

1.4K Views

article

4.5 : 리간드 게이트 이온 채널 수용체: 게이팅 메커니즘

Pharmacodynamics

1.7K Views

article

4.6 : 변환기 메커니즘: 효소 결합 수용체

Pharmacodynamics

2.0K Views

article

4.7 : 트랜스듀서 메커니즘: 핵 수용체

Pharmacodynamics

962 Views

article

4.8 : 용량-반응 관계: 개요

Pharmacodynamics

2.1K Views

article

4.9 : 용량-반응 관계: 효능 및 효능

Pharmacodynamics

3.1K Views

article

4.10 : 용량-반응 관계: 선택성 및 특이성

Pharmacodynamics

5.7K Views

article

4.11 : 치료 지수

Pharmacodynamics

3.4K Views

article

4.12 : 약물-수용체 상호작용: 작용제

Pharmacodynamics

1.9K Views

article

4.14 : 약물의 복합 효과: 길항작용

Pharmacodynamics

6.6K Views

article

4.15 : 약물의 복합 효과: 시너지 효과

Pharmacodynamics

2.3K Views

See More

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유